FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024363295> ?p ?o ?g. }

• W2024363295 endingPage "883" @default.
• W2024363295 startingPage "877" @default.
• W2024363295 abstract "We observed 3 patients who developed severe venous and arterial thromboembolic events during treatment with adalimumab, 2 of whom had rheumatoid arthritis (RA) and 1 of whom had psoriatic arthritis. Antiadalimumab antibodies were detected in all 3 patients. We undertook this study to determine whether the development of antiadalimumab antibodies was associated with thromboembolic events during adalimumab treatment.A retrospective search (with blinding with regard to antiadalimumab antibody status) for thromboembolic events was performed in a prospective cohort of 272 consecutively included adalimumab-treated RA patients. Incidence rates were calculated and hazard ratios (HRs) were estimated using Cox regression. None of the index patients were part of the cohort.Antiadalimumab antibodies were detected in 76 of 272 patients (28%). Eight thromboembolic events were found, 4 of which had occurred in patients with antiadalimumab antibodies. The incidence rate was 26.9/1,000 person-years for patients with antiadalimumab antibodies and 8.4/1,000 person-years for patients without those antibodies (HR 3.8 [95% confidence interval 0.9-15.3], P = 0.064). After adjustment for duration of followup, age, body mass index, erythrocyte sedimentation rate, and prior thromboembolic events, the HR was 7.6 (95% confidence interval 1.3-45.1) (P = 0.025).These findings suggest that the occurrence of venous and arterial thromboembolic events during adalimumab treatment is higher in patients with antiadalimumab antibodies than in those without antiadalimumab antibodies. Patient numbers were relatively small; therefore, validation in other cohorts is mandatory." @default.
• W2024363295 created "2016-06-24" @default.
• W2024363295 creator A5012564728 @default.
• W2024363295 creator A5017243329 @default.
• W2024363295 creator A5024214678 @default.
• W2024363295 creator A5029733252 @default.
• W2024363295 creator A5032846595 @default.
• W2024363295 creator A5052169703 @default.
• W2024363295 creator A5054704301 @default.
• W2024363295 creator A5067384016 @default.
• W2024363295 creator A5075695885 @default.
• W2024363295 creator A5085213730 @default.
• W2024363295 creator A5090033299 @default.
• W2024363295 creator A5090448389 @default.
• W2024363295 date "2011-03-30" @default.
• W2024363295 modified "2023-10-18" @default.
• W2024363295 title "Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: A case series and cohort study" @default.
• W2024363295 cites W1601972531 @default.
• W2024363295 cites W1971973021 @default.
• W2024363295 cites W1975033484 @default.
• W2024363295 cites W1977979834 @default.
• W2024363295 cites W1984413085 @default.
• W2024363295 cites W1992628263 @default.
• W2024363295 cites W1997999969 @default.
• W2024363295 cites W2017883234 @default.
• W2024363295 cites W2031889731 @default.
• W2024363295 cites W2036687266 @default.
• W2024363295 cites W2039804759 @default.
• W2024363295 cites W2043097326 @default.
• W2024363295 cites W2093911903 @default.
• W2024363295 cites W2110177517 @default.
• W2024363295 cites W2119046820 @default.
• W2024363295 cites W2125139860 @default.
• W2024363295 cites W2136418163 @default.
• W2024363295 cites W2150378917 @default.
• W2024363295 cites W2155991992 @default.
• W2024363295 cites W2166771071 @default.
• W2024363295 cites W2168841149 @default.
• W2024363295 cites W2169304723 @default.
• W2024363295 cites W2177368405 @default.
• W2024363295 doi "https://doi.org/10.1002/art.30209" @default.
• W2024363295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21452312" @default.
• W2024363295 hasPublicationYear "2011" @default.
• W2024363295 type Work @default.
• W2024363295 sameAs 2024363295 @default.
• W2024363295 citedByCount "105" @default.
• W2024363295 countsByYear W20243632952012 @default.
• W2024363295 countsByYear W20243632952013 @default.
• W2024363295 countsByYear W20243632952014 @default.
• W2024363295 countsByYear W20243632952015 @default.
• W2024363295 countsByYear W20243632952016 @default.
• W2024363295 countsByYear W20243632952017 @default.
• W2024363295 countsByYear W20243632952018 @default.
• W2024363295 countsByYear W20243632952019 @default.
• W2024363295 countsByYear W20243632952020 @default.
• W2024363295 countsByYear W20243632952021 @default.
• W2024363295 countsByYear W20243632952022 @default.
• W2024363295 countsByYear W20243632952023 @default.
• W2024363295 crossrefType "journal-article" @default.
• W2024363295 hasAuthorship W2024363295A5012564728 @default.
• W2024363295 hasAuthorship W2024363295A5017243329 @default.
• W2024363295 hasAuthorship W2024363295A5024214678 @default.
• W2024363295 hasAuthorship W2024363295A5029733252 @default.
• W2024363295 hasAuthorship W2024363295A5032846595 @default.
• W2024363295 hasAuthorship W2024363295A5052169703 @default.
• W2024363295 hasAuthorship W2024363295A5054704301 @default.
• W2024363295 hasAuthorship W2024363295A5067384016 @default.
• W2024363295 hasAuthorship W2024363295A5075695885 @default.
• W2024363295 hasAuthorship W2024363295A5085213730 @default.
• W2024363295 hasAuthorship W2024363295A5090033299 @default.
• W2024363295 hasAuthorship W2024363295A5090448389 @default.
• W2024363295 hasBestOaLocation W20243632951 @default.
• W2024363295 hasConcept C120665830 @default.
• W2024363295 hasConcept C121332964 @default.
• W2024363295 hasConcept C126322002 @default.
• W2024363295 hasConcept C141071460 @default.
• W2024363295 hasConcept C207103383 @default.
• W2024363295 hasConcept C2777575956 @default.
• W2024363295 hasConcept C2780132546 @default.
• W2024363295 hasConcept C44249647 @default.
• W2024363295 hasConcept C61511704 @default.
• W2024363295 hasConcept C71924100 @default.
• W2024363295 hasConcept C72563966 @default.
• W2024363295 hasConcept C90924648 @default.
• W2024363295 hasConceptScore W2024363295C120665830 @default.
• W2024363295 hasConceptScore W2024363295C121332964 @default.
• W2024363295 hasConceptScore W2024363295C126322002 @default.
• W2024363295 hasConceptScore W2024363295C141071460 @default.
• W2024363295 hasConceptScore W2024363295C207103383 @default.
• W2024363295 hasConceptScore W2024363295C2777575956 @default.
• W2024363295 hasConceptScore W2024363295C2780132546 @default.
• W2024363295 hasConceptScore W2024363295C44249647 @default.
• W2024363295 hasConceptScore W2024363295C61511704 @default.
• W2024363295 hasConceptScore W2024363295C71924100 @default.
• W2024363295 hasConceptScore W2024363295C72563966 @default.
• W2024363295 hasConceptScore W2024363295C90924648 @default.
• W2024363295 hasIssue "4" @default.
• W2024363295 hasLocation W20243632951 @default.

• next